Research Triangle Park

Highwoods Announces Recent Disposition Activity

Retrieved on: 
Thursday, April 4, 2024
GAAP, Research Triangle Park, HIW, Triangle Park (Quezon City), Sale, UNC Rex Healthcare, Bank

RALEIGH, N.C., April 04, 2024 (GLOBE NEWSWIRE) -- Highwoods Properties, Inc. (NYSE:HIW) has sold in a series of transactions non-core properties in Raleigh for combined gross proceeds of $79.4 million.

Key Points: 
  • RALEIGH, N.C., April 04, 2024 (GLOBE NEWSWIRE) -- Highwoods Properties, Inc. (NYSE:HIW) has sold in a series of transactions non-core properties in Raleigh for combined gross proceeds of $79.4 million.
  • Gross proceeds from dispositions closed in the first quarter of 2024 totaled $16.9 million with the remainder closing early in the second quarter.
  • As part of the sale of one building, the Company provided $6.2 million in non-recourse first mortgage seller financing.
  • The note is scheduled to mature in February 2025, but can be prepaid without penalty at any time prior to maturity.

Merakris Therapeutics to Release Final Part 1 Data From Phase 2 Multicenter Investigational Drug Study for Dermacyte® Liquid

Retrieved on: 
Tuesday, February 20, 2024
Research Triangle Park, Triangle Park (Quezon City), FDA, Part, Vein, Leg, Skin, Conference, Veterans' affairs, Safety, Therapy, Patent, Part 1, Patient, PST, Clinical trial, Ulcer, Pharmaceutical industry

RESEARCH TRIANGLE PARK, N.C., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Merakris Therapeutics announced that it will present encouraging safety and efficacy data from the first of a two-part Phase 2 multi-center clinical study of its investigational wound care drug, Dermacyte® Amniotic Wound Care Liquid.

Key Points: 
  • RESEARCH TRIANGLE PARK, N.C., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Merakris Therapeutics announced that it will present encouraging safety and efficacy data from the first of a two-part Phase 2 multi-center clinical study of its investigational wound care drug, Dermacyte® Amniotic Wound Care Liquid.
  • The study consented 12 patients who were assessed for eligibility to receive the investigational drug treatment.
  • Preliminary data indicate an 84% average reduction in ulcer surface area for the 9 patients completing the 12-week study.
  • These data are being analyzed by the Merakris scientific team and an independent data safety and monitoring committee and will inform the design of Part 2 of the multi-center clinical study.

Alcami Opens New Advanced Pharma Storage and Services Facility in Central North Carolina

Retrieved on: 
Wednesday, January 24, 2024
Temperature, CGMP, RTP, Tissue, Golden Joystick Awards, GMP, Acquisition, Triangle Park (Quezon City), ICH, Research Triangle Park, CDMO, Vaccine

DURHAM, N.C., Jan. 24, 2024 /PRNewswire/ -- Alcami Corporation ("Alcami"), a leading contract development and manufacturing organization (CDMO), today announced the opening of its new 65,000 ft² state-of-the-art Pharma Storage and Services operations facility in Garner, North Carolina close to the Research Triangle Park biotech and pharma hub.

Key Points: 
  • - Ambient storage now open for shipments, with stability storage, aliquoting and cold storage phasing in later in 2024
    DURHAM, N.C., Jan. 24, 2024 /PRNewswire/ -- Alcami Corporation ("Alcami"), a leading contract development and manufacturing organization (CDMO), today announced the opening of its new 65,000 ft² state-of-the-art Pharma Storage and Services operations facility in Garner, North Carolina close to the Research Triangle Park biotech and pharma hub.
  • The new central North Carolina facility, now accepting client pallets for ambient/controlled room temperature storage, adds to the company's network of GMP storage facilities across North America.
  • Part of the company's intentional strategy to strengthen its pharma storage and services business with key locations to streamline operations for biotech and pharma clients, the site will phase in stability storage and aliquoting, followed by cold storage later this year.
  • "As pressures intensify to outsource GMP storage of biopharmaceutical materials and products for cost savings that can fuel clients' R&D and other projects, our new RTP pharma storage and services facility is well-positioned to fill this previously unmet market demand," said Laurent Boer, President, Alcami Pharma Storage and Services.

Alcami Announces Acquisition of West-Coast Based Pacific Pharmaceutical Services

Retrieved on: 
Wednesday, January 17, 2024
PPS, Research Triangle Park, CDMO, CGMP, Acquisition, Temperature, Fine chemical

DURHAM, N.C., Jan. 17, 2024 /PRNewswire/ -- Alcami Corporation ("Alcami"), a leading contract development and manufacturing organization (CDMO), announced today it has completed the acquisition of Pacific Pharmaceutical Services, Inc. ("PPS"), a preferred provider of cGMP pharma storage and services.

Key Points: 
  • DURHAM, N.C., Jan. 17, 2024 /PRNewswire/ -- Alcami Corporation ("Alcami"), a leading contract development and manufacturing organization (CDMO), announced today it has completed the acquisition of Pacific Pharmaceutical Services, Inc. ("PPS"), a preferred provider of cGMP pharma storage and services.
  • "The Pacific Pharmaceutical Services acquisition is part of our highly intentional strategy to supercharge the capabilities of our pharma storage and services business with locations that best serve biotech and pharma clients across the country," commented Bill Humphries, CEO of Alcami.
  • Combined with the acquisition, this additional expansion underscores Alcami's focus on its comprehensive pharma storage and services business.
  • Similarly, Alcami's extensive client base will have access to PPS' West Coast cGMP pharma storage capacity and support services, ensuring a seamless experience across the Alcami network of laboratory, pharma storage and manufacturing services.

LifeScience Logistics Expands Raleigh-Durham Presence with Second Pharmaceutical Storage and Distribution Facility for Pharmaceutical and Medical Device Manufacturers

Retrieved on: 
Friday, January 5, 2024
Research Triangle, Research Triangle Park, API, Business, FDA, LSL, Triangle Park (Quezon City), Heart, Business development, SF, Warehouse

This facility will be LSL’s 17th strategic location across the United States and the second location added to the Raleigh-Durham hub.

Key Points: 
  • This facility will be LSL’s 17th strategic location across the United States and the second location added to the Raleigh-Durham hub.
  • This innovative 249,600 SF facility, located in the heart of Research Triangle Park, will expand LSL’s capacity to provide FDA-registered, cGMP-compliant, temperature-controlled storage and end-to-end 3PL solutions to pharmaceutical and medical device manufacturers operating in the Raleigh-Durham area.
  • “We decided to build an additional facility to support the unprecedented demand for both pharmaceutical and medical device temperature-controlled storage and distribution in the Raleigh-Durham region.”
    LSL anticipates strong demand for the solutions offered in their latest Raleigh-Durham facility.
  • The new location will ensure the safe and compliant storage of finished goods, API, raw materials, and packaging materials.

Moa Technology hires for further growth with expansion of its leadership team – announcing appointment of CFO and US-based CBO to support advancement of next-generation herbicides

Retrieved on: 
Monday, November 20, 2023
Triangle Park (Quezon City), Corporation, Silence Therapeutics, Research, Research Triangle Park, Bachelor of Science, Business development, Therapy, CFO, Flagship Pioneering, University College Dublin, Biology, Bayer, GSK, Farmer, Health, Mergers and acquisitions, MBA, University, Growth, Doctor of Philosophy, Bioherbicide, Control, Newcastle University, Herbicide, CBO, Management, Pharmaceutical industry, Telescopic sight, Agriculture, Biochemistry, Syngenta, Apostolos, Moa

He has extensive experience of helping biotech companies raise funding, both through equity funding and industry collaborations.

Key Points: 
  • He has extensive experience of helping biotech companies raise funding, both through equity funding and industry collaborations.
  • His appointment also reflects Moa’s use of cutting-edge biotechnology processes to identify, understand and develop next-generation herbicides with game-changing speed and accuracy.
  • Without effective herbicides, farmers can lose up to 40% of their crop yield as a result of weed growth.
  • Dr. Virginia Corless, Chief Executive Officer of Moa Technology, says:
    “Moa is tackling a major crisis that threatens farmers’ livelihoods and global food security.

BASF opens the door for career paths in modern manufacturing with new apprenticeship opportunities

Retrieved on: 
Tuesday, November 14, 2023
MAKE, Woman, Research Triangle Park, National Association of Manufacturers, Chattanooga State Community College, National Association, BASF, Work, NAM, One America Initiative, Female, Nursing

Among the new BASF sites welcoming apprentices in 2023 are Port Arthur, TX; Pasadena, TX; Malcom, IA; Southfield, MI; and Research Triangle Park, NC.

Key Points: 
  • Among the new BASF sites welcoming apprentices in 2023 are Port Arthur, TX; Pasadena, TX; Malcom, IA; Southfield, MI; and Research Triangle Park, NC.
  • “The manufacturing industry depends on well-trained employees to help drive our businesses as well as economic growth in the communities in which we live and work.
  • Upon completion of the apprenticeship program, participants will have the skills and credentials needed to launch their careers in manufacturing.
  • “BASF’s apprenticeship program gave me great insight into manufacturing and provided me the opportunity to connect in-class learning with my job responsibilities,” said Samuel Blackwell, a Tennessee-based graduate of BASF’s apprenticeship program.

CTI Expands AV Services to Research Triangle

Retrieved on: 
Wednesday, November 29, 2023
Research, Research Triangle Park, CTI, Flexible, Interior design

 RALEIGH, N.C., Nov. 29, 2023 /PRNewswire/ -- CTI, the largest privately held AV integration and events provider in the U.S., has opened a new office in Raleigh, North Carolina, offering installations and service to Research Triangle Park and the greater Research Triangle Area. This is the company's thirty-fourth location. CTI serves customers nationwide, with locations spread from Michigan to Texas, New Jersey to California, and worldwide as a member of the PSNI Global Alliance.

Key Points: 
  • "We're excited to open the new office in the Research Triangle!"
  • says John Laughlin, CEO of CTI , "This is our third East Coast location, and between Research Triangle Park, dozens of the biggest tech and life science companies in the world, three major research universities, and a host of smaller colleges, we look forward to bringing our Fast, Fair, and Flexible solutions and service to new customers and better serve our existing clients."

Donaldson Company Invests in New Life Sciences Technical Center

Retrieved on: 
Thursday, November 9, 2023
Research, Infectious Diseases, Genetics, Health Technology, Biometrics, Biotechnology, Pharmaceutical, Health, Science, Other Science, Solaris, RTP, AAV, NYSE, Research Triangle Park, Donaldson Company, Multimedia, DCI, Donaldson, Fine chemical

Donaldson Company, Inc. (NYSE: DCI), a leading worldwide provider of innovative filtration products and solutions, announced its commitment to broadening its life sciences reach with the opening of a 25,000-square-foot life sciences technical center in Research Triangle Park (RTP).

Key Points: 
  • Donaldson Company, Inc. (NYSE: DCI), a leading worldwide provider of innovative filtration products and solutions, announced its commitment to broadening its life sciences reach with the opening of a 25,000-square-foot life sciences technical center in Research Triangle Park (RTP).
  • Donaldson brands located or under development at the facility include Isolere Bio, Purilogics, Solaris Biotech and Univercells Technologies.
  • It also will serve as a hub for Donaldson life science innovations while advancing the IsoTag™ reagent product line.
  • “By adding manufacturing capacity, Donaldson is in a stronger position to support customers in their research through clinical and commercial-scale activities.”

Women-owned Startups Collaborate Toward a Scalable and Cost-Effective Future for Sustainable Biotechnology

Retrieved on: 
Thursday, October 26, 2023
Science, Genetic distance, Health, Research Triangle Park, Biotechnology, Carbon, Triangle Park (Quezon City), Milk, Protein, Infant formula, Growth, A-DNA, Alexandria Center of Arts, Plant, Tiamat, Breast milk, Prolactin, Hormone, Woman, Regenerative medicine, Lactation, Fine chemical, Dairy

By leveraging the potential of human mammary cells, BIOMILQ can bring more of the functional benefits of breast milk to more babies.

Key Points: 
  • By leveraging the potential of human mammary cells, BIOMILQ can bring more of the functional benefits of breast milk to more babies.
  • BIOMILQ and Tiamat Sciences are both headquartered in the Alexandria Center for AgTech – Research Triangle Park, a hub for emerging and global agtech companies.
  • In three months, Tiamat Sciences successfully produced Human Prolactin, a vital biomolecule for lactation, using an entirely animal-free production process.
  • BIOMILQ is a women-owned and science-led mammary biotechnology start-up leveraging its patented technology to produce functional cell-cultured human milk components outside of the body.